ArticleFrontiers in oncology2021

Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Shuang Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.